Gilead Sciences
Search results
We are one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. 13th Largest Pharma Company in India, In terms of Domestic Sales for MAT September 2023
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules (both softgel capsules and hard-gel capsules) and injectables.
Emcure Pharmaceuticals is driven by the purpose to develop, manufacture and market a broad range of pharmaceutical products globally. Our core strength and competitive advantage lie in our established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS & HIV among others.
15 hours ago · Emcure Pharmaceuticals initial public offering is set to open for subscription on Wednesday, July, 3, 2024. The IPO comprises a fresh issue of 7.9 million shares totaling Rs 800.00 crores and an offer for sale of 11.4 million shares amounting to Rs 1,152.03 crores. The pharma company raised Rs 582 ...
2 days ago · Emcure Pharmaceuticals IPO is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximately Rs 1,952 crore through the public offer. Market analysts indicate that the current GMP of the pharma company stands at Rs 260 in the unlisted market.
Emcure Pharmaceuticals is a fast-growing Indian pharmaceutical company engaged in developing, manufacturing & marketing a broad range of pharmaceutical products globally.
17 hours ago · Emcure Pharmaceuticals is engaged in developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company is a research ...
11 hours ago · Emcure Pharma IPO: The initial public offering of Emcure Pharmaceuticals Ltd, which is backed by Bain Capital, was opened for public subscription today, July 3. The Rs 1,952-crore IPO, which will conclude on July 5, has already been fully subscribed on the first day of bidding. Till 03:29 pm on Wednesday, the Rs 1,952.03-crore IPO received 100 per cent subscription garnering bids for 1,37,40,832 shares as against 1,37,03,538 shares on offer.
Emcure Pharmaceuticals is one of the leading Indian pharmaceutical company with a differentiated product portfolio. With its wide range of offerings, Emcure Pharmaceuticals has cemented its presence in over 70 countries around the world.
Aug 5, 2021 · Emcure Pharmaceuticals, a leading pharmaceutical company engaged in developing, manufacturing & marketing a wide range of pharmaceutical products globally.
